Skip to main content
Download PDF

Volume 20 Supplement 1

Designing, implementing and evaluating a community-based intervention to prevent diabetes in vulnerable families across Europe. The Feel4Diabetes-study.

Obtaining evidence base for the development of Feel4Diabetes intervention to prevent type 2 diabetes – a narrative literature review

BMC Endocrine Disorders volume 20, Article number: 140 (2020) Cite this article

Abstract

Background

Feel4Diabetes was a school and community based intervention aiming to promote healthy lifestyle and tackle obesity for the prevention of type 2 diabetes among families in 6 European countries. We conducted this literature review in order to guide the development of evidence-based implementation of the Feel4Diabetes intervention. We focused on type 2 diabetes prevention strategies, including all the phases from risk identification to implementation and maintenance. Special focus was given to prevention among vulnerable groups and people under 45 years.

Methods

Scientific and grey literature published between January 2000 and January 2015 was searched for relevant studies using electronic databases. To present the literature review findings in a systematic way, we used the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. A complementary literature search from February 2015 to December 2018 was also conducted.

Results

The initial review included 27 studies with a follow-up ≥12 months and 9 studies with a follow-up ≥6 months and with a participant mean age < 45 years. We found out that interventions should be targeted at people at risk to improve recruiting and intervention effectiveness. Screening questionnaires (primarily Finnish Diabetes Risk Score FINDRISC) and blood glucose measurement can both be used for screening; the method does not appear to affect intervention effectiveness. Screening and recruitment is time-consuming, especially when targeting lower socioeconomic status and age under 45 years. The intervention intensity is more important for effectiveness than the mode of delivery. Moderate changes in several lifestyle habits lead to good intervention results. A minimum of 3-year follow-up seemed to be required to show a reduction in diabetes risk in high-risk individuals. In participants < 45 years, the achieved results in outcomes were less pronounced. The complementary review included 12 studies, with similar results regarding intervention targets and delivery modes, as well as clinical significance.

Conclusion

This narrative review highlighted several important aspects that subsequently guided the development of the Feel4Diabetes high-risk intervention. Research on diabetes prevention interventions targeted at younger adults or vulnerable population groups is still relatively scarce. Feel4Diabetes is a good example of a project aiming to fill this research gap.

Trial registration

clinicaltrials.gov NCT02393872, registered 20th March 2015.

Background

The number of people with type 2 diabetes is reaching epidemic proportions all over the world [1]. In Western societies, a social gradient in the prevalence of type 2 diabetes and its risk factors is also well-documented, vulnerable population groups having greater burden than those in higher social strata [2,3,4]. The clinical manifestation of type 2 diabetes usually appears later in life, but many of the risk factors and behaviours develop much earlier and many disparities in health are rooted already early in life. The prevalence of the disease is growing also in younger individuals as a result of increasing obesity rates, unhealthy diet and physical inactivity already present during childhood [1].

Tackling the type 2 diabetes epidemic is a major public health challenge. Most of the diabetes prevention interventions so far have been targeted at middle-aged people who already have non-diabetic hyperglycaemia [5,6,7]. These interventions are highly warranted, as identified high-risk individuals cannot be left untreated and the achieved risk reduction has been shown to be most pronounced among individuals who are already close to the diagnostic limit [8]. However, to achieve largest impact on population level, prevention emphasizing healthy lifestyle should be started already during childhood and continued throughout the life course. A new challenge is to learn from the previous type 2 diabetes interventions and tailor them for younger individuals who have traditionally been considered as low risk and who therefore have not received the appropriate attention [9].

The objective of the Feel4Diabetes project was to develop, implement and evaluate a school-, community- and family-based intervention program for the prevention of type 2 diabetes among vulnerable families with children in primary school, in six European countries during 2015–2019 [10]. The 2-year intervention included two components: “all families component” and “high-risk families component”. The all families component was targeted at school-aged children and their families and tailored to improve the diet, physical activity patterns, and body weight according to national guidelines. A school setting was chosen to reach families with different socioeconomic backgrounds and to utilize the school as an intervention venue. Feel4Diabetes also focused on areas with lower socioeconomic status to reach the most vulnerable populations for type 2 diabetes.

The parents of the participating families filled FINDRISC-questionnaire and the parents with high risk scores were invited to participate in type 2 diabetes prevention study, e.g. the high-risk families component. These parents got in addition to school based activities more intensive intervention, including individual and group sessions about type 2 diabetes, healthy eating and exercising following a SMS intervention based on tips and reminds about healthy lifestyle. Feel4Diabetes-study was registered in clinicaltrials.gov with registration number NCT02393872.

As part of the PRECEDE phase of the PRECEDE-PROCEED model of Feel4Diabetes [11] several literature searches were completed, to guide the development of evidence-based implementation of the Feel4Diabetes intervention. In addition to this review focusing on adults, a review focusing on studies implemented in school setting aiming to enhance healthy lifestyle in children was conducted [12]. The aim of the work presented in this paper was to systematically review the available research literature on type 2 diabetes prevention strategies targeted at adult high-risk individuals and find state-of-the-art methods in all phases from risk identification to implementation and maintenance to use in Feel4Diabetes high-risk families component. The primary literature search was conducted in 2015 before beginning of the Feel4Diabetes-study and updated in 2019 to provide a comprehensive review of the subject. Specifically, our aim was to pinpoint effective type 2 diabetes prevention strategies regarding vulnerable population groups, as well as strategies that have been successfully implemented among under middle-aged population groups.

Methods

Search strategy

For the primary literature search conducted in 2015 a search strategy was developed in consultation with an information specialist. The information specialist completed three searches using search terms related to ‘diabetes’, ‘prevention’, ‘intervention’ and ‘efficacy’. The first search was a general search for diabetes prevention interventions from scientific literature in OvidSP (MEDLINE), Web of Science, EBSCOhost and Cochrane databases. The second search was targeted to interventions on vulnerable populations and in addition to search terms used in search one, the term ‘vulnerability’ and related terms were used. The third literature search was completed to find grey literature using Open Grey, Greylit -reports, NICE Evidence Search and Google search engines with same search terms as in the first one. The question about identification of high risk adults was explored in the context of preventive interventions. The information specialist did preliminary selection according to the search strategy. Two reviewers independently examined titles and abstracts and selected relevant articles according to inclusion criteria. In case of disagreement, inclusion was resolved through discussion.

The complementary literature search was done in 2019 to update the original work with the most recent type 2 diabetes prevention studies. The search terms used were the same as in first search for the primary literature review and the search was done using PubMed (MEDLINE). The complementary search was done by one reviewer and the search was complemented using cross-references in the already included publications and reviews to ensure coverage.

Inclusion and exclusion criteria

Inclusion criteria based on title and abstract were:

  1. 1.

    Type of study: Randomized controlled studies (RCT) or pre-post intervention studies that considered the effectiveness of a lifestyle intervention (diet and/or exercise).

  2. 2.

    The stated aim of the study: type 2 diabetes risk reduction or prevention of type 2 diabetes.

  3. 3.

    Population: Adults (18 years and over) identified as being at high risk of developing type 2 diabetes identified having prevalent risk factors (for example obesity, sedentary lifestyle, family history of diabetes, metabolic syndrome, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), prediabetes, hyperlipidemia, gestational diabetes, cardiovascular disease, elevated diabetes risk score or elevated cardiovascular risk score).

  4. 4.

    Outcome of the study: Development of diabetes or change in diabetes risk, measured by a reliable and scientifically approved risk marker like weight, body mass index (BMI), fasting glucose or glucose tolerance.

  5. 5.

    Study published: in the English language and as full-length articles between January 1st, 2000 and January 29th, 2015 in primary search OR between January 29th, 2015 and February 28th 2019 in complementary search

  6. 6.

    Follow-up time of at least 12 months OR at least 6 months if median/mean age of participants was < 45 years

After the selection of relevant publications based on abstracts (n = 232 in the primary search), the publications originating from the same study were combined, the full-length papers were acquired and read. Studies were excluded if they did not meet the inclusion (if the study was not RCT or pre-post study, the aim was not to prevent type 2 diabetes, participants inclusion was not based on type 2 diabetes risk, the outcome was not a measured risk marker for type 2 diabetes or the article was not in English and published before January 2000) criteria or the study population included a large proportion of people with diabetes (over one fourth), the results of the primary endpoints were not published or follow-up time was less than 6 months. Originally, we decided to exclude studies with less than 12 months follow-up time, to emphasize the evidence on long-term effectiveness of the intervention. However, as the research including younger participants (< 45 years of age) proved to be scarce, we modified the criteria to include studies with at least 6 months follow-up time if they included participants within the age range of 18 to 45 years.

Data synthesis

The selected publications (n = 80) in the primary search showed that the majority of the published diabetes prevention studies have been targeted at older population groups than the target group of the Feel4Diabetes intervention (parents with school-aged children). It is known that increasing age is a significant risk factor for type 2 diabetes and the study by Deeks et al. [13] found age dependent differences in health beliefs and screening participation rates. Older people were more likely to participate in specific health checks including blood glucose and cholesterol measurement than younger people. Presumably older people have different life circumstances and thus different barriers for participation and changing lifestyles compared with younger ones. Relying on studies with mainly older participants (as those with sole number override the studies on younger people) might have steered the conclusions off target. Therefore, two different review approaches were conducted. In first approach the studies with the participants aged ≥18 years and minimum follow-up of 12 months (n = 27) were reviewed. In second approach the studies with mean or median age of participants less than 45 years and minimum follow-up of 6 months (n = 9) were included. In the complementary search all studies had follow-up time over 12 months (n = 10). A flow chart of the selection of relevant studies is presented in Fig. 1.

Fig. 1
figure 1

Flow chart of the literature review process

Full size image

To present the findings from the literature reviews in a systematic way, we used the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework designed for assessing interventions and public health programs [14]. The overall goal of the RE-AIM framework is to encourage implementers to pay more attention to core elements, which can improve adoption and implementation interventions.

The summary tables of the selected studies (see Tables 1, 2 and 3) were prepared and reviewers independently evaluated the clinical significance of the results presented for each study, to facilitate interpretation of the effectiveness versus the design, methods, delivery, and costs of intervention. The clinical significance of the study results was scored as follows: meaningful reduction in diabetes risk; meaningful improvement in (most) target risk factors; meaningful improvement in some/few risk factors; or no effect.

Table 1 Overview of the studies targeting participants aged ≥ 18 years and minimum follow-up of 12 months
Full size table
Table 2 Overview of the studies targeting participants age 18–45 years and with minimum follow-up time 6 months
Full size table
Table 3 Overview of the studies in the complementary search for studies published between January 2015 and January 2019
Full size table

Results

In the primary literature review of publications dated Jan 2000-Jan 2015, searches identified 663 potentially relevant publications, of which 80 studies met the initial inclusion criteria. For the first approach, altogether 27 studies targeted at population aged ≥18 years were reviewed after discarding the studies with the follow-up time under 12 months (Table 1). Of these, 12 were completed in Europe [6, 26, 29, 30, 32, 33, 35, 37, 41, 48, 55, 86], five in the USA [36, 44, 45, 50, 87], three in China [5, 47, 54], four in Japan [22, 28, 51], two in India [52, 88] and one in Australia [31].

In the second approach, the inclusion criteria of participants’ mean age ≤ 45 and follow-up at least 6 months were fulfilled only in nine studies, of which two were completed in Europe [26, 48], five in the USA or Canada [36, 57, 58, 60, 62], and two in China [5, 54] (Table 2). There were five studies which fulfilled inclusion criteria for both reviews [5, 26, 36, 48, 54].

The complementary search found 12 studies published after January 2015 (Table 3). In brief, six studies were conducted in USA [63, 64, 66,67,68,69,70,71,72, 75,76,77] (most were based on the DPP intervention implemented with adaptations in various settings), two in Spain [65, 78,79,80], two in India [74, 81,82,83,84], one in Israel [85] and one in Malaysia [73]. All 12 studies had a mean follow-up of at least 12 months and 5 included younger individuals (mean age ≤ 45 years old) [65, 72, 74,75,76, 85] and another three reported a mean participant age of ≤50 years old [66,67,68,69,70,71]. The core elements of the implementation of the high-risk intervention were identified through a synthesis of selected studies using RE-AIM model [14].

The core elements of implementation

Reach

The total number of participants was over 13,000 in the studies with the participants aged ≥18 years and minimum follow-up of 12 months. Most common inclusion criteria in these studies were IGT or IFG based on laboratory tests (mentioned in 16 studies). In addition to laboratory tests, the FINDRISC diabetes risk score was used as an inclusion method in five studies [30, 32, 35, 37, 41] and used as a pre-screening instrument in one study [30]. Three studies used other risk scores (e.g. AUSDRISC) or risk algorithms for inclusion [26, 33, 44]. In addition, previous gestational diabetes was the basis of inclusion in one study [54], and BMI in another study [36]. It appears that none of the risk identification methods was superior as regards to the subsequent effectiveness of the intervention. The process of screening and recruitment was often reported to be laborious and more time-consuming than expected. When initial contact was not targeted at a risk population, the final inclusion was in general less than 10%, for example 0.5% in Da Qing [5], 2% in the Diabetes Prevention Program (DPP) [87] and approximately 10% in the Diabetes Prevention Study (DPS) [6]. The proportion of included subjects was lower in studies that had higher baseline risk (e.g. IGT) as an inclusion criterion. Only two studies stated that they were targeted at “underserved” or socioeconomically “vulnerable” population groups [36, 44]. Both of them showed significant improvement in target risk factors. In addition, two studies [37, 48] either included or were targeted solely at minority groups such as immigrants.

From the studies targeted at less than 45 years old participants, the major difficulties were related to participation. Lack of interest to take part in the studies was common and the drop-out rates tended to be in general high and participation in interventions in general inadequate. For example in The Families united study only 18 participants, of 90 eligible screened, attended the 12 month follow-up [58] and in DH!AAN only 22–26% of participants attended the lifestyle sessions. Some studies had completed focus group interviews and engaged the community already in the planning phase [49], but that did not have an unambiguous effect on the actual participation or the achieved lifestyle changes. Inviting people from e.g. registers as opposed to asking volunteers with self-perceived risk to sign up has been especially challenging and the response rate has generally been low. The participant selection method has also been reflected in attendance in interventions and evaluation measurements (especially in control groups or control areas), resulting in higher attrition. Five out of the nine studies, with the participants aged ≤45 years and the minimum follow-up of 6 months, were targeted at “vulnerable” population groups, such as native North Americans [57], public housing communities [60] or underserved Latino population in USA [36], or immigrants in the Netherlands [48]. The results from these studies were comparable to other 4 studies targeting general high diabetes risk population.

In complementary search 5 studies were targeted on vulnerable groups, one on economically disadvantaged adults [64], one on African-Americans in Georgia US [66], one on low-income Hispanic women [75], one on Socioeconomically disadvantaged Hispanic females in Philadelphia [75, 76] and one in developing country [81].

Adoption and implementation

In most of the studies with follow-up time over 12 months, the lifestyle goals were based on DPP or DPS and were related to body weight (reduction 5–7% recommended), changes in diet and increase in physical activity. Frequent dietary goals were to increase fibre, whole grains, fruit and vegetables, and to reduce total, saturated and/or trans-fat, sugar, refined carbohydrates, starch, alcohol and/or total calorie consumption. Also diet related lifestyle targets such as “reducing the frequency of eating out” were mentioned as target [22]. The studies differed from each other in relation to what and how much each target was emphasized. The participants in Chinese studies were not in general overweight at baseline, so weight reduction target was typical only for the subgroup of overweight or obese people [5]. In the PREDIMED-Reus study completed in Spain and emphasizing Mediterranean diet enriched with extra-virgin olive oil or nuts, there was neither weight reduction (despite high rate of obesity) nor physical activity target but yet a significant reduction in diabetes risk was observed [33].

Coach-delivered, face-to-face, individual (n = 11), group (n = 7), or group-individual-combination (n = 5) interventions were the most common delivery modes. In addition, in one study [28], intervention was delivered in hospital (in-patient) and in one study [37] intervention personnel went to the family homes. Short message system (SMS) was used in two studies [47, 52] as the primary intervention method. In addition, some studies used phone calls and telefax. SMSs proved to be a promising way to deliver intervention in a cost-effective way. The intensity of intervention (number and frequency of counselling sessions/contacts between the personnel and the participants) appeared to be more important for effective intervention than the mode. The coach has most often been either a nurse or a dietician. As long as the coach is trained appropriately to do the intervention and applies a structured intervention curriculum, there does not seem to be a big difference between professions.

Several theories of behaviour change were applied as the basis for the interventions. The most often mentioned theory was the stages of change/trans-theoretical model [24, 36, 41, 51, 52, 89] (applied in 6 interventions), followed by the theory of self-regulation (in three interventions) [26, 30, 31], the theory of planned behaviour (in 2 interventions) [26, 47], social cognitive theory of behaviour change (in two interventions) [44, 47], and the health action process approach, HAPA (in one intervention) [31]. None of the theories seemed to be unequivocally better or worse than the other and many of the highly successful studies have not stated specifically relying on an overarching theory of behaviour change. The reason for this might be that even though the theories have differing background presumptions about the process of behavioural change they utilize more or less the same components, techniques and tools, such as motivational interviewing, social and peer support, interactive learning strategies, behavioural support on goal-setting and self-monitoring, problem-solving and feedback. Of the two studies using SMS, the Indian study [53] utilized the tailoring of the messages based on individuals’ estimated stage of change and showed significantly better results compared with the Chinese study [47] using generic messages. The studies where motivation of participants was emphasized were successful. In many studies, self-monitoring and personal goal setting were seen as very important. In less successful studies there was a high drop-out rate, which might be related to motivation. In the studies targeted at less than 45 years old participants, the results of the intervention did not seem to depend on the theoretical framework or, whether there was a theoretical framework mentioned at all. However, several authors still emphasized the need for a theoretical framework and structured intervention. Most studies, however, described components, techniques, and tools that are included in many of these theories.

The feedback from those who actually participated in the interventions was in general very positive. The authors’ recommendation in several studies was not to cut down the number of contacts/sessions and topics, as this would lead to dissatisfaction by the participants, but to increase the number of sessions and offer the sessions with shorter intervals, paying special attention to accessibility such as timing of the sessions and e.g. offering child care when needed. Also offering a variety of intervention modes (individual, group, SMS, telephone, DVD, internet) to choose from was considered a feasible strategy to reach participants in studies with mean age under 45 years old. Incentives for participation were recommended by some authors. Community partnership was considered important to train and support community health workers. However, employing full-time project staff as opposed to expecting local community workers to do the project in addition to their normal work was emphasized. One study (Families United) [58] aimed at recruiting a family member as a support person but that proved to be a challenge.

The complementary search showed that the basic contents of the interventions in the recent studies had not changed from the first diabetes prevention projects. Most studies applied traditional intervention modes, i.e. group and/or individual counselling sessions based on behavioural change techniques delivered by health professionals or trained non-medical community members. As reported in previously published studies, non-medical individuals delivered efficient interventions. Many studies highlighted the importance of attendance for intervention efficacy and the need of strategies to increase and sustain patient engagement; among studies targeted on women with GDM and on people with low socioeconomic status, adequate attendance was promoted through family involvement and childcare offer [70,71,72]. Also the community, in many innovative ways, was utilised as an intervention or recruiting place, for example the church as an intervention state for African-Americans [66], a workplace for employees in information technology industry as the recruiting and intervention venue [74] and peer-led intervention as a way to involve community in a study in India [84]. In the study using telephone/newsletter [70, 71] and the study using SMS/email technology [74] to deliver the intervention the results were comparable with others. Lifestyle advice through telecommunication was considered as an efficient, low-cost and potentially scalable intervention for technology-literate individuals. Even though different mobile phone applications, activity trackers and other modern technology have become widely available, the technology was not systematically used in modern studies.

Efficacy and maintenance

Of the 27 studies including the participants aged ≥18 years old and minimum follow-up of 12 months, eight [5,6,7, 22, 23, 28, 33, 40] were rated highly successful and showing meaningful reduction in diabetes incidence. In seven studies [30, 32, 35, 36, 44, 45, 50], meaningful improvement in (most) target risk factors were seen; in those studies reduction of diabetes incidence was either not a target or not achieved. In eight studies [29, 37, 41, 51, 54, 55], meaningful reduction in some/few risk factors was achieved. Only four studies [26, 31, 47, 48] failed to show any effect on risk factors or diabetes risk. In most studies including younger participants (18–45 years old), achieved results/changes in predefined outcome variables were less-pronounced than in studies with older participants. The exception for this rule was the Chinese Da Qing study [5], where a significant and highly meaningful reduction in diabetes risk in 6 years was achieved. However, also in that study there was no reduction in body weight in general, and the measured changes in diet and physical activity were modest. In general the achieved lifestyle changes were minor compared with changes in the studies on older participants. This might be due to lower self-perceived risk and life situation in general, such as “demands of motherhood and family life” as stated in one of the studies [54].

In the complementary search significant reduction in diabetes risk was distinguished in the two studies conducted in Spain of all 12 reviewed studies [4, 79, 80]. Both of these studies were conducted at a medical environment (primary health-care centres or hospital) by medical personnel, applied intensive interventions in terms of patient contact and reinforcement and had a long follow-up period of 2 and 3 years. In 8 studies significant reductions in most of targeted diabetes risk factors were achieved but reduction in diabetes risk was not stated. In two studies significant reductions were achieved only in some diabetes risk factors [63, 64, 75, 76]. In those studies, diabetes risk assessment for recruitment was based on Hb1Ac levels, which may have led to recruiting participants with relatively low baseline fasting glucose values and without room for improvement. Significant changes in glycaemic control were not seen, although interventions were efficient in achieving weight loss and improving body composition.

Discussion

The systematic literature reviews revealed and highlighted several important aspects that were subsequently taken into account while developing the Feel4Diabetes high-risk intervention. To improve effectiveness as well as sustainable adoption and implementation of interventions, they should be targeted at people with increased type 2 diabetes risk. Risk identification can be based on fasting or 2 h blood glucose measurement, however, also non-invasive methods can be used. Since the publication of the FINDRISC in 2003 it has been used in several studies as the first-line or even sole risk screening tool. In the major type 2 diabetes prevention trials [6, 90] the oral glucose tolerance test was used as the screening method and IFG or IGT as inclusion criteria. In the studies included in this review, the risk identification method appeared not to be associated with the effectiveness of the intervention. The selection of risk identification method may thus be based on pragmatic issues such as cost, acceptability, and accessibility, especially when completing an implementation project. Of note, the measurement of glycated haemoglobin (HbA1c) has been found clearly inferior to oral glucose tolerance test (OGTT) in identification of prediabetes based on the meta-analysis by Barry et al. [91]. An important finding was that the process of screening and recruitment is often laborious and more time-consuming than expected; especially people with lower socioeconomic status may require additional effort and action. Thus, screening is a critical step of preventive interventions and should not be overlooked. Most studies included in this review show that changes in diabetes risk factors are similar regardless of whether the intervention is delivered by experts (clinically trained health professionals) or lay educators; therefore, costs associated with diabetes prevention can be lowered without sacrificing intervention effectiveness, involving nonmedical personnel.

Equally important is to arrange the intervention so that it is easily and conveniently accessible. In the younger age-group, the most important reasons for non-participation were lack of time and difficulties in participating in the scheduled counselling sessions. Furthermore, in most studies including younger participants (18–45 years old), achieved results/changes in predefined outcome variables were less-pronounced than in studies with older participants. Obvious reason for this is that a longer follow-up is needed to see effect on diabetes risk in younger people. The complementary literature search showed that the same challenges of recruitment and participant engagement continue in recent studies as in previous studies. Wider use of modern technology could help participants to commit on the intervention and the use of different community settings were seen helping the recruitment. Even in the most recent studies technology was quite rarely used, even though it was seen as efficient as the classic face-to-face counselling. Targeting intervention earlier in life might be a trend in most recent studies, 40% of studies conducted between 2015 and 2019 was targeted to people under 45 years old. Technology could be part of a solution to engage and reach younger participants.

The focus and general goal of intervention should be clearly specified and communicated. Cultural adjustments to the intervention goals probably increase the participation and motivation to make the suggested lifestyle changes. The intensity of intervention (number and frequency of counselling sessions/contacts between the personnel and the participants) is more important for effective intervention than the mode of delivery. Moderate but comprehensive changes in several lifestyles seem to lead to a good intervention effect. At least 3 years follow-up seemed to be required to show actual reduction in diabetes risk in high-risk individuals.

Theoretical model is considered important as a framework for the intervention. However, as long as it facilitates the understanding of the complexity of behavioural change, it doesn’t matter which model is used. Tools and methods shown to be efficacious include motivational interviewing, social and peer support, interactive learning and motivation and self-efficacy building strategies, support on individualized goal-setting, self-monitoring, problem solving, relapse management, and feedback.

Importantly, research on prevention interventions targeted at younger adults or vulnerable population groups such as people with lower socioeconomic position proved to be surprisingly scarce. More research is warranted, and Feel4Diabetes is an important example of projects aiming to fill this research gap.

Conclusions

This narrative review highlighted several important aspects that subsequently guided the development of the Feel4Diabetes high-risk intervention. Research on diabetes prevention interventions targeted at younger adults or vulnerable population groups is still relatively scarce. Feel4Diabetes is a good example of a project aiming to fill this research gap.

Availability of data and materials

Not applicable.

Abbreviations

BMI:

Body mass index

DPP:

Diabetes Prevention Program

DPS:

Diabetes Prevention Study

HAPA:

Health Action Process Approach

HbA1c:

Glycated haemoglobin

IFG:

Impaired fasting glucose

IGT:

Impaired glucose tolerance

OGTT:

Oral glucose tolerance test

RE-AIM:

Reach, Effectiveness, Adoption, Implementation, and Maintenance

SMART goals:

Specific, Measurable, Attainable, Realistic and Timely goals

SMS:

Short message system

References

  1. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.

    Article  CAS  PubMed  Google Scholar 

  2. Espelt A, Borrell C, Roskam A, Rodríguez-Sanz M, Stirbu I, Dalmau-Bueno A, Regidor E, Bopp M, Martikainen P, Leinsalu M, Artnik B, Rychtarikova J, Kalediene R, Dzurova D, Mackenbach J, Kunst A. Socioeconomic inequalities in diabetes mellitus across Europe at the beginning of the 21st century. Diabetologia. 2008;51(11):1971–9.

    Article  CAS  PubMed  Google Scholar 

  3. Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk A. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011;40(3):804–18.

    Article  PubMed  Google Scholar 

  4. Sacerdote C, Ricceri F, Rolandsson O, Baldi I, Chirlaque MD, Feskens E, Bendinelli B, Ardanaz E, Arriola L, Balkau B, Bergmann M, Beulens JW, Boeing H, Clavel-Chapelon F, Crowe F, de Lauzon-Guillain B, Forouhi N, Franks PW, Gallo V, Gonzalez C, Halkjaer J, Illner AK, Kaaks R, Key T, Khaw KT, Navarro C, Nilsson PM, Dal Ton SO, Overvad K, Pala V, Palli D, Panico S, Polidoro S, Quiros JR, Romieu I, Sanchez MJ, Slimani N, Sluijs I, Spijkerman A, Teucher B, Tjonneland A, Tumino R, van der AD VAC, Wennberg P, Sharp S, Langenberg C, Riboli E, Vineis P, Wareham N. Lower educational level is a predictor of incident type 2 diabetes in European countries: the EPIC-InterAct study. Int J Epidemiol. 2012;41(4):1162–73.

    Article  PubMed  Google Scholar 

  5. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennet PH, Howard BV. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care. 1997;20:537–44.

    Article  CAS  PubMed  Google Scholar 

  6. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Finnish diabetes prevention study group: prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.

    Article  CAS  PubMed  Google Scholar 

  7. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Diabetes prevention program research group: reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.

    Article  CAS  PubMed  Google Scholar 

  8. Lindström J, Peltonen M, Eriksson JG, Aunola S, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J. Finnish diabetes prevention study (DPS) group: determinants for the effectiveness of lifestyle intervention in the Finnish diabetes prevention study. Diabetes Care. 2008;31(5):857–62.

    Article  PubMed  CAS  Google Scholar 

  9. Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69–80.

    Article  PubMed  Google Scholar 

  10. Manios Y, Androutsos O, Lambrinou CP, Cardon G, Lindström J, Annemans L, Mateo-Gallego R, de Sabata MS, Iotova V, Kivelä J, Martinez R, Moreno LA, Rurik I, Schwarz P, Tankova T, Liatis S, Makrilakis K. A school- and community-based intervention to promote healthy lifestyle and prevent type 2 diabetes in vulnerable families across Europe: design and implementation of the Feel4Diabetes-study. Public Health Nutr. 2018;21(17):3281–90.

    Article  PubMed  Google Scholar 

  11. Green LW. Health program planning: an educational and ecological approach: 4th ed. New York. London: McGraw-Hill; 2005.

    Google Scholar 

  12. Lambrinou CP, Androutsos O, Karalgani E, Cardon G, Hyus N, Van Stappen V, Wikström K, Kivelä J, Ko W, Karuranga E, Tsochev K, Iotova V, Dimova R, Tamás H, Jancsó Z, Liatis S, Makrilakis K, Manios Y. Effective strategies in childhood obesity prevention interventions at the primary-school setting: A narrative review for the development of the Feel4Diabetes-study intervention. BMC Endocr Disord. In press.

  13. Deeks A, Lombard C, Michelmore J, Teede H. The effects of gender and age on health related behaviors. BMC Public Health. 2009;9:213. https://doi.org/10.1186/1471-2458-9-213.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013;103(6):e38–46.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study. Lancet. 2008;371(9626):1783–9.

    Article  PubMed  Google Scholar 

  16. Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J, Finnish Diabetes Prevention Study Group. The Finnish diabetes prevention study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230–6.

    Article  PubMed  Google Scholar 

  17. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Hemiö K, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J, Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish diabetes prevention study. Lancet. 2006;368(9548):1673–9.

    Article  PubMed  Google Scholar 

  18. Lindström J, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J, Finnish Diabetes Prevention Study (DPS). Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish diabetes prevention study (DPS). Diabetologia. 2013;56(2):284–93.

    Article  PubMed  Google Scholar 

  19. Wikström K, Peltonen M, Eriksson JG, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J, Lindström J. Educational attainment and effectiveness of lifestyle intervention in the Finnish diabetes prevention study. Diabetes Res Clin Pract. 2009;86(1):e1–5.

    Article  PubMed  Google Scholar 

  20. Rubin RR, Fujimoto WY, Marrero DG, Brenneman T, Charleston JB, Edelstein SL, Fisher EB, Jordan R, Knowler WC, Lichterman LC, Prince M, Rowe PM, DPP Research Group. The diabetes prevention program: recruitment methods and results. Control Clin Trials. 2002;23(2):157–71.

    Article  PubMed  Google Scholar 

  21. Fujimoto WY, Diabetes Prevention Program Research Group: Background and recruitment data for the U.S. Diabetes Prevention Program. Diabetes Care 2000, 23 Suppl 2:B11–3.

  22. Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract. 2005;67:152–62.

    Article  PubMed  Google Scholar 

  23. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, Indian diabetes prevention Programme (IDPP). The Indian diabetes prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–97.

    Article  CAS  PubMed  Google Scholar 

  24. Oldroyd JC, Unwin NC, White M, Mathers JC, Alberti KG. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Res Clin Pract. 2006;72(2):117–27.

    Article  PubMed  Google Scholar 

  25. Oldroyd JC, Unwin NC, White M, Imrie K, Mathers JC, Alberti KG. Randomised controlled trial evaluating the effectiveness of behavioural interventions to modify cardiovascular risk factors in men and women with impaired glucose tolerance: outcomes at 6 months. Diabetes Res Clin Pract. 2001;52(1):29–43.

    Article  CAS  PubMed  Google Scholar 

  26. Lakerveld J, Bot S, Chinapaw M, van Tulder M, Kingo L, Nijpels G. Process evaluation of a lifestyle intervention to prevent diabetes and cardiovascular diseases in primary care. Health Promot Pract. 2012;13(5):696–706.

    Article  PubMed  Google Scholar 

  27. Lakerveld J, Bot SD, Chinapaw MJ, van Tulder MW, Kostense PJ, Dekker JM, Nijpels G. Motivational interviewing and problem solving treatment to reduce type 2 diabetes and cardiovascular disease risk in real life: a randomized controlled trial. Int J Behav Nutr Phys Act. 2013;10:47. https://doi.org/10.1186/1479-5868-10-47.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kawahara T, Takahashi K, Inazu T, Arao T, Kawahara C, Tabata T, Moriyama H, Okada Y, Morita E, Tanaka Y. Reduced progression to type 2 diabetes from impaired glucose tolerance after a 2-day in-hospital diabetes educational program: the Joetsu diabetes prevention trial. Diabetes Care. 2008;31(10):1949–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Penn L, White M, Oldroyd J, Walker M, Alberti KG, Mathers JC: Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK. BMC Public Health 2009, 9:342–2458–9-342.

  30. Kulzer B, Hermanns N, Gorges D, Schwarz P, Haak T. Prevention of diabetes self-management program (PREDIAS): effects on weight, metabolic risk factors, and behavioral outcomes. Diabetes Care. 2009;32(7):1143–6.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Dunbar J, Davis-Lameloise N, Philpot B, Reddy P, Bunker S, Heistaro J, Laatikainen T, Janus E. Sustained gains from a diabetes prevention program and the role of telephone support. Int J Diab Mellitus. 2010;2(2):95–100.

    Article  Google Scholar 

  32. Makrilakis K, Liatis S, Grammatikou S, Perrea D, Katsilambros N. Implementation and effectiveness of the first community lifestyle intervention programme to prevent type 2 diabetes in Greece. The DE-PLAN study Diabet Med. 2010;27(4):459–65.

    Article  CAS  PubMed  Google Scholar 

  33. Salas-Salvado J, Bullo M, Babio N, Martinez-Gonzalez MA, Ibarrola-Jurado N, Basora J, Estruch R, Covas MI, Corella D, Aros F, Ruiz-Gutierrez V, Ros E. PREDIMED study investigators: reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care. 2011;34(1):14–9.

    Article  PubMed  Google Scholar 

  34. Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ros E, Covas MI, Fiol M, Warnberg J, Aros F, Ruiz-Gutierrez V, Lamuela-Raventos RM, Lapetra J, Munoz MA, Martinez JA, Saez G, Serra-Majem L, Pinto X, Mitjavila MT, Tur JA, Portillo MP, Estruch R, PREDIMED Study Investigators. Cohort profile: design and methods of the PREDIMED study. Int J Epidemiol. 2012;41(2):377–85.

    Article  PubMed  Google Scholar 

  35. Gilis-Januszewska A, Szybinski Z, Kissimova-Skarbek K, Piwonska-Solska B, Pach D, Topor-Madry R, Tuomilehto J, Lindström J, Peltonen M, Schwarz PE, Hubalewska-Dydejczyk A. Prevention of type 2 diabetes by lifestyle intervention in primary health care setting in Poland: diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Br J Diabetes Vascular Dis. 2011;11(4):198–203.

    Article  CAS  Google Scholar 

  36. Ruggiero L, Oros S, Choi YK. Community-based translation of the diabetes prevention program's lifestyle intervention in an underserved Latino population. Diabetes Educ. 2011;37(4):564–72.

    Article  PubMed  Google Scholar 

  37. Bhopal RS, Douglas A, Wallia S, Forbes JF, Lean ME, Gill JM, McKnight JA, Sattar N, Sheikh A, Wild SH, Tuomilehto J, Sharma A, Bhopal R, Smith JB, Butcher I, Murray GD. Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. Lancet Diabetes Endocrinol. 2014;2(3):218–27.

    Article  PubMed  Google Scholar 

  38. Douglas A, Bhopal RS, Bhopal R, Forbes JF, Gill JM, McKnight J, Murray G, Sattar N, Sharma A, Wallia S, Wild S, Sheikh A: Design and baseline characteristics of the PODOSA (Prevention of Diabetes & Obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetes. BMJ Open 2013, 3(2):https://doi.org/10.1136/bmjopen-2012-002226. Print 2013.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Douglas A, Bhopal RS, Bhopal R, Forbes JF, Gill JM, Lawton J, McKnight J, Murray G, Sattar N, Sharma A, Tuomilehto J, Wallia S, Wild SH, Sheikh A. Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes & Obesity in South Asians). Trials. 2011;12:220. https://doi.org/10.1186/1745-6215-12-220.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Saito T, Watanabe M, Nishida J, Izumi T, Omura M, Takagi T, Fukunaga R, Bandai Y, Tajima N, Nakamura Y, Ito M, Zensharen Study for Prevention of Lifestyle Diseases Group. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch Intern Med. 2011;171(15):1352–60.

    Article  PubMed  Google Scholar 

  41. Vermunt PW, Milder IE, Wielaard F, de Vries JH, van Oers HA, Westert GP. Lifestyle counseling for type 2 diabetes risk reduction in Dutch primary care: results of the APHRODITE study after 0.5 and 1.5 years. Diabetes Care. 2011;34(9):1919–25.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Vermunt PW, Milder IE, Wielaard F, Baan CA, Schelfhout JD, Westert GP, van Oers HA. Implementation of a lifestyle intervention for type 2 diabetes prevention in Dutch primary care: opportunities for intervention delivery. BMC Fam Pract. 2012;13:79.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Vermunt PW, Milder IE, Wielaard F, de Vries JH, Baan CA, van Oers JA, Westert GP. A lifestyle intervention to reduce type 2 diabetes risk in Dutch primary care: 2.5-year results of a randomized controlled trial. Diabet Med. 2012;29(8):e223–31.

    Article  CAS  PubMed  Google Scholar 

  44. Ockene IS, Tellez TL, Rosal MC, Reed GW, Mordes J, Merriam PA, Olendzki BC, Handelman G, Nicolosi R, Ma Y. Outcomes of a Latino community-based intervention for the prevention of diabetes: the Lawrence Latino diabetes prevention project. Am J Public Health. 2012;102(2):336–42.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Xiao L, Yank V, Wilson SR, Lavori PW, Ma J. Two-year weight-loss maintenance in primary care-based diabetes prevention program lifestyle interventions. Nutr Diabetes. 2013;3:e76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Ma J, Yank V, Xiao L, Lavori PW, Wilson SR, Rosas LG, Stafford RS. Translating the diabetes prevention program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern Med. 2013;173(2):113–21.

    Article  PubMed  Google Scholar 

  47. Wong CK, Fung CS, Siu SC, Lo YY, Wong KW, Fong DY, Lam CL. A short message service (SMS) intervention to prevent diabetes in Chinese professional drivers with pre-diabetes: a pilot single-blinded randomized controlled trial. Diabetes Res Clin Pract. 2013;102(3):158–66.

    Article  PubMed  Google Scholar 

  48. Admiraal WM, Vlaar EM, Nierkens V, Holleman F, Middelkoop BJ, Stronks K, van Valkengoed IG. Intensive lifestyle intervention in general practice to prevent type 2 diabetes among 18 to 60-year-old south Asians: 1-year effects on the weight status and metabolic profile of participants in a randomized controlled trial. PLoS One. 2013;8(7):e68605.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Vlaar EM, van Valkengoed IG, Nierkens V, Nicolaou M, Middelkoop BJ, Stronks K. Feasibility and effectiveness of a targeted diabetes prevention program for 18 to 60-year-old South Asian migrants: design and methods of the DH!AAN study. BMC Public Health. 2012;12:371. https://doi.org/10.1186/1471-2458-12-371.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Kramer MK, Miller RG, Siminerio LM. Evaluation of a community diabetes prevention program delivered by diabetes educators in the United States: one-year follow up. Diabetes Res Clin Pract. 2014;106(3):e49–52.

    Article  PubMed  Google Scholar 

  51. Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tominaga M, Kawazu S, Sato Y, Usui T, Kamae I, Yoshida T, Kiyohara Y, Sato S, Tsuzaki K, Takahashi K, Kuzuya H. Japan diabetes prevention program (JDPP) research group: effect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan diabetes prevention program. BMJ Open Diabetes Res Care. 2014;2(1):e000003.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Nanditha A, Ram J, Snehalatha C, Selvam S, Priscilla S, Shetty AS, Arun R, Godsland IF, Johnston DG, Ramachandran A. Early improvement predicts reduced risk of incident diabetes and improved cardiovascular risk in prediabetic Asian Indian men participating in a 2-year lifestyle intervention program. Diabetes Care. 2014;37(11):3009–15.

    Article  CAS  PubMed  Google Scholar 

  53. Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, Shetty AS, Godsland IF, Chaturvedi N, Majeed A, Oliver N, Toumazou C, Alberti KG, Johnston DG. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2013;1(3):191–8.

    Article  PubMed  Google Scholar 

  54. Shek NW, Ngai CS, Lee CP, Chan JY, Lao TT. Lifestyle modifications in the development of diabetes mellitus and metabolic syndrome in Chinese women who had gestational diabetes mellitus: a randomized interventional trial. Arch Gynecol Obstet. 2014;289(2):319–27.

    Article  PubMed  Google Scholar 

  55. Viitasalo K, Lindström J, Hemiö K, Puttonen S, Koho A, Härmä M, Peltonen M. Occupational health care identifies risk for type 2 diabetes and cardiovascular disease. Prim Care Diabetes. 2012;6(2):95–102.

    Article  PubMed  Google Scholar 

  56. Viitasalo K, Hemiö K, Puttonen S, Hyvärinen HK, Leiviskä J, Härmä M, Peltonen M, Lindström J. Prevention of diabetes and cardiovascular diseases in occupational health care: feasibility and effectiveness. Prim Care Diabetes. 2015;9(2):96–104.

    Article  PubMed  Google Scholar 

  57. Ho LS, Gittelsohn J, Rimal R, Treuth MS, Sharma S, Rosecrans A, Harris SB. An integrated multi-institutional diabetes prevention program improves knowledge and healthy food acquisition in northwestern Ontario first nations. Health Educ Behav. 2008;35(4):561–73.

    Article  PubMed  Google Scholar 

  58. Perez Siwik V, Kutob RM, Ritenbaugh C, Aickin M, Gordon JS. Families united/Familias Unidas: development and implementation of a family-based group office visit model for the primary prevention of type 2 diabetes. Diabetes Educ. 2012;38(6):811–21.

    Article  PubMed  Google Scholar 

  59. Kutob RM, Siwik VP, Aickin M, Ritenbaugh C. Families united/Familias Unidas: family group office visits to reduce risk factors for type 2 diabetes. Diabetes Educ. 2014;40(2):191–201.

    Article  PubMed  Google Scholar 

  60. Whittemore R, Rosenberg A, Jeon S. A diabetes prevention program provided by home care nurses to residents of public housing communities. J Health Disparities Res Pract. 2013;6(1):14–29.

    Google Scholar 

  61. Whittemore R, Rosenberg A, Gilmore L, Withey M, Breault A. Implementation of a diabetes prevention program in public housing communities. Public Health Nurs. 2014;31(4):317–26.

    Article  PubMed  Google Scholar 

  62. Philis-Tsimikas A, Fortmann AL, Dharkar-Surber S, Euyoque JA, Ruiz M, Schultz J, Gallo LC. Dulce mothers: an intervention to reduce diabetes and cardiovascular risk in Latinas after gestational diabetes. Transl Behav Med. 2014;4(1):18–25.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Ackermann RT, Finch EA, Schmidt KK, Hoen HM, Hays LM, Marrero DG, Saha C. Rationale, design, and baseline characteristics of a community-based comparative effectiveness trial to prevent type 2 diabetes in economically disadvantaged adults: the RAPID study. Contemp Clin Trials. 2014;37(1):1–9.

    Article  PubMed  Google Scholar 

  64. Ackermann RT, Liss DT, Finch EA, Schmidt KK, Hays LM, Marrero DG, Saha C. A randomized comparative effectiveness trial for preventing type 2 diabetes. Am J Public Health. 2015;105(11):2328–34.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Perez-Ferre N, Del Valle L, Torrejon MJ, Barca I, Calvo MI, Matia P, Rubio MA, Calle-Pascual AL. Diabetes mellitus and abnormal glucose tolerance development after gestational diabetes: a three-year, prospective, randomized, clinical-based, Mediterranean lifestyle interventional study with parallel groups. Clin Nutr. 2015;34(4):579–85.

    Article  CAS  PubMed  Google Scholar 

  66. Dodani S, Kramer MK, Williams L, Crawford S, Kriska A. Fit body and soul: a church-based behavioral lifestyle program for diabetes prevention in African Americans. Ethn Dis. 2009;19(2):135–41.

    PubMed  Google Scholar 

  67. Williams LB, Sattin RW, Dias J, Garvin JT, Marion L, Joshua T, Kriska A, Kramer MK, Echouffo-Tcheugui JB, Freeman A, Narayan KM. Design of a cluster-randomized controlled trial of a diabetes prevention program within African-American churches: the fit body and soul study. Contemp Clin Trials. 2013;34(2):336–47.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Sattin RW, Williams LB, Dias J, Garvin JT, Marion L, Joshua TV, Kriska A, Kramer MK, Narayan KM. Community trial of a faith-based lifestyle intervention to prevent diabetes among African-Americans. J Community Health. 2016;41(1):87–96.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Rhodes EC, Chandrasekar EK, Patel SA, Venkat Narayan KM, Joshua TV, Williams LB, Marion L, Ali MK. Cost-effectiveness of a faith-based lifestyle intervention for diabetes prevention among African Americans: a within-trial analysis. Diabetes Res Clin Pract. 2018;146:85–92.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Ferrara A, Hedderson MM, Albright CL, Brown SD, Ehrlich SF, Caan BJ, Sternfeld B, Gordon NP, Schmittdiel JA, Gunderson EP, Mevi AA, Tsai AL, Ching J, Crites Y, Quesenberry CP Jr. A pragmatic cluster randomized clinical trial of diabetes prevention strategies for women with gestational diabetes: design and rationale of the Gestational Diabetes' Effects on Moms (GEM) study. BMC Pregnancy Childbirth. 2014;14:21. https://doi.org/10.1186/1471-2393-14-21.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Ferrara A, Hedderson MM, Brown SD, Albright CL, Ehrlich SF, Tsai AL, Caan BJ, Sternfeld B, Gordon NP, Schmittdiel JA, Gunderson EP, Mevi AA, Herman WH, Ching J, Crites Y, Quesenberry CP Jr. The comparative effectiveness of diabetes prevention strategies to reduce postpartum weight retention in women with gestational diabetes mellitus: the gestational Diabetes' effects on moms (GEM) cluster randomized controlled trial. Diabetes Care. 2016;39(1):65–74.

    Article  CAS  PubMed  Google Scholar 

  72. Van Name MA, Camp AW, Magenheimer EA, Li F, Dziura JD, Montosa A, Patel A, Tamborlane WV. Effective translation of an intensive lifestyle intervention for Hispanic women with Prediabetes in a community health center setting. Diabetes Care. 2016;39(4):525–31.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Ibrahim N, Ming Moy F, Awalludin IA, Mohd Ali Z, Ismail IS. Effects of a community-based healthy lifestyle intervention program (co-HELP) among adults with Prediabetes in a developing country: a quasi-experimental study. PLoS One. 2016;11(12):e0167123.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  74. Limaye T, Kumaran K, Joglekar C, Bhat D, Kulkarni R, Nanivadekar A, Yajnik C. Efficacy of a virtual assistance-based lifestyle intervention in reducing risk factors for type 2 diabetes in young employees in the information technology industry in India: LIMIT, a randomized controlled trial. Diabet Med. 2017;34(4):563–8.

    Article  CAS  PubMed  Google Scholar 

  75. Perez A, Alos VA, Scanlan A, Maia CM, Davey A, Whitaker RC, Foster GD, Ackermann RT, O'Brien MJ. The rationale, design, and baseline characteristics of PREVENT-DM: A community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes. Contemp Clin Trials. 2015;45(Pt B):320–7.

    Article  PubMed  PubMed Central  Google Scholar 

  76. O'Brien MJ, Perez A, Scanlan AB, Alos VA, Whitaker RC, Foster GD, Ackermann RT, Ciolino JD, Homko C. PREVENT-DM comparative effectiveness trial of lifestyle intervention and metformin. Am J Prev Med. 2017;52(6):788–97.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Kramer MK, Vanderwood KK, Arena VC, Miller RG, Meehan R, Eaglehouse YL, Schafer G, Venditti EM, Kriska AM. Evaluation of a diabetes prevention program lifestyle intervention in older adults: a randomized controlled study in three senior/community centers of varying socioeconomic status. Diabetes Educ. 2018;44(2):118–29.

    Article  PubMed  Google Scholar 

  78. Sanchez A, Silvestre C, Sauto R, Martinez C, Grandes G, PreDE research group. Feasibility and effectiveness of the implementation of a primary prevention programme for type 2 diabetes in routine primary care practice: a phase IV cluster randomised clinical trial. BMC Fam Pract. 2012;13:109. https://doi.org/10.1186/1471-2296-13-109.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Sanchez A, Silvestre C, Campo N, Grandes G, PreDE research group. Type-2 diabetes primary prevention program implemented in routine primary care: a process evaluation study. Trials. 2016;17(1):254. https://doi.org/10.1186/s13063-016-1379-0.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Sanchez A, Silvestre C, Campo N, Grandes G, PredDE group. Effective translation of a type-2 diabetes primary prevention programme into routine primary care: the PreDE cluster randomised clinical trial. Diabetes Res Clin Pract. 2018;139:32–42.

    Article  PubMed  Google Scholar 

  81. Sathish T, Williams ED, Pasricha N, Absetz P, Lorgelly P, Wolfe R, Mathews E, Aziz Z, Thankappan KR, Zimmet P, Fisher E, Tapp R, Hollingsworth B, Mahal A, Shaw J, Jolley D, Daivadanam M, Oldenburg B. Cluster randomised controlled trial of a peer-led lifestyle intervention program: study protocol for the Kerala diabetes prevention program. BMC Public Health. 2013;13:1035. https://doi.org/10.1186/1471-2458-13-1035.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Mathews E, Thomas E, Absetz P, D'Esposito F, Aziz Z, Balachandran S, Daivadanam M, Thankappan KR, Oldenburg B. Cultural adaptation of a peer-led lifestyle intervention program for diabetes prevention in India: the Kerala diabetes prevention program (K-DPP). BMC Public Health. 2018;17(1):974 -017-4986-0.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Aziz Z, Mathews E, Absetz P, Sathish T, Oldroyd J, Balachandran S, Shetty SS, Thankappan KR, Oldenburg B. A group-based lifestyle intervention for diabetes prevention in low- and middle-income country: implementation evaluation of the Kerala diabetes prevention program. Implement Sci. 2018;13(1):97 -018-0791-0.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Thankappan KR, Sathish T, Tapp RJ, Shaw JE, Lotfaliany M, Wolfe R, Absetz P, Mathews E, Aziz Z, Williams ED, Fisher EB, Zimmet PZ, Mahal A, Balachandran S, D'Esposito F, Sajeev P, Thomas E, Oldenburg B. A peer-support lifestyle intervention for preventing type 2 diabetes in India: a cluster-randomized controlled trial of the Kerala diabetes prevention program. PLoS Med. 2018;15(6):e1002575.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Zilberman-Kravits D, Meyerstein N, Abu-Rabia Y, Wiznitzer A, Harman-Boehm I. The impact of a cultural lifestyle intervention on metabolic parameters after gestational diabetes mellitus a randomized controlled trial. Matern Child Health J. 2018;22(6):803–11.

    Article  PubMed  Google Scholar 

  86. Oldroyd J, Banerjee M, Heald A, Cruickshank K, Oldroyd J, Banerjee M, Heald A, Cruickshank K. Diabetes and ethnic minorities. Postgrad Med J. 2005;81(958):486–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. The Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care. 2003;26(1):36–47.

    Article  Google Scholar 

  88. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. Indian diabetes prevention P: the Indian diabetes prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289–97.

    Article  CAS  PubMed  Google Scholar 

  89. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka O, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.

    Article  CAS  PubMed  Google Scholar 

  90. The Diabetes Prevention Program Research Group. Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program. Diabetes Care. 2003;26(4):977–80.

    Article  Google Scholar 

  91. Barry E, Roberts S, Oke J, Vijayaraghavan S, Normansell R, Greenhalgh T. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ. 2017;356:i6538.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank our information specialist in National institute for health and welfare, Mari Mäkinen, who helped us to develop the search strategy for literature and searched databases. The authors would like to thank the members of the Feel4Diabetes-study Group Coordinator: Yannis Manios, Steering Committee: Yannis Manios, Greet Cardon, Jaana Lindström, Peter Schwarz, Konstantinos Makrilakis, Lieven Annemans, Ignacio Garamendi, Harokopio University (Greece): Yannis Manios, Meropi Kontogianni, Odysseas Androutsos, Christina Mavrogianni, Konstantina Tsoutsoulopoulou, Christina Katsarou, Eva Karaglani, Irini Qira, Efstathios Skoufas, Konstantina Maragkopoulou, Antigone Tsiafitsa, Irini Sotiropoulou, Michalis Tsolakos, Effie Argyri, Mary Nikolaou, Eleni-Anna Vampouli, Christina Filippou. Katerina Gatsiou, Efstratios Dimitriadis, National Institute for Health and Welfare (Finland): Jaana Lindström, Tiina Laatikainen, Katja Wikström, Jemina Kivelä, Päivi Valve, Esko Levälahti, Eeva Virtanen, Ghent University (Belgium): Department of Movement and Sports Sciences: Greet Cardon, Vicky Van Stappen, Nele Huys; Department of Public Health: Lieven Annemans, Ruben Willems; Department of Endocrinology and Metabolic Diseases: Samyah Shadid, Technische Universität Dresden (Germany): Peter Schwarz, Ivonne Panchyrz, Maxi Holland, Patrick Timpel, National and Kapodistrian University of Athens (Greece): Konstantinos Makrilakis, Stavros Liatis, George Dafoulas, Christina-Paulina Lambrinou, Angeliki Giannopoulou, Lydia Tsirigoti, Evi Fappa, Costas Anastasiou, Konstantina Zachari, International Diabetes Federation Europe (Belgium): Lala Rabemananjara, Maria Stella de Sabata, Winne Ko, Ignacio Garamendi, Universidad De Zaragoza (Spain): Luis Moreno, Fernando Civeira, Gloria Bueno, Pilar De Miguel-Etayo, Esther Mª Gonzalez-Gil, Maria I Mesana, Germán Vicente-Rodriguez, Gerardo Rodriguez, Lucia Baila-Rueda, Ana Cenarro, Estíbaliz Jarauta, Rocío Mateo-Gallego, Medical University of Varna (Bulgaria): Violeta Iotova, Tsvetalina Tankova, Natalia Usheva, Kaloyan Tsochev, Nevena Chakarova, Sonya Galcheva, Rumyana Dimova, Yana Bocheva, Zhaneta Radkova, Vanya Marinova, Yuliya Bazdarska, Tanya Stefanova, University of Debrecen (Hungary): Imre Rurik, Timea Ungvari, Zoltán Jancsó, Anna Nánási, László Kolozsvári, Csilla Semánova, Extensive Life Oy (Finland): Remberto Martinez, Marcos Tong, Kaisla Joutsenniemi, Katrina Wendel-Mitoraj.

About this supplement

This article has been published as part of BMC Endocrine Disorders, Volume 20 Supplement 1, 2020: Designing, implementing and evaluating a community-based intervention to prevent diabetes in vulnerable families across Europe. The Feel4Diabetes-study. The full contents of the supplement are available at https://bmcendocrdisord.biomedcentral.com/articles/supplements/volume-20-supplement-1.

Funding

Publication of this supplement was funded by the European Union’s Horizon 2020 research and innovation program under grant agreement n° 643708. The content of this article reflects only the authors’ views and the European Community is not liable for any use that may be made of the information contained therein.

Author information

Authors and Affiliations

  1. Department of Public Health Solutions, National Institute for Health and Welfare, PO BOX 27, 00300, Helsinki, Finland

    Jemina Kivelä, Katja Wikström, Eeva Virtanen & Jaana Lindström

  2. Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland

    Jemina Kivelä

  3. Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland

    Katja Wikström

  4. Department of Nutrition and Dietetics, Harokopio University, Athens, Greece

    Michael Georgoulis & Yannis Manios

  5. Department of Movement and Sports Sciences, Ghent University, Ghent, Belgium

    Greet Cardon & Vicky Van Stappen

  6. GENUD (Growth, Exercise, Nutrition and Development) Research Group, University of Zaragoza, Zaragoza, Spain

    Fernando Civeira & Rocío Mateo-Gallego

  7. Department of Paediatrics, Medical University Varna, Varna, Bulgaria

    Violeta Iotova & Kaloyan Tsochev

  8. International Diabetes Federation, Brussels, Belgium

    Ernest Karuranga & Winne Ko

  9. National and Kapodistrian University of Athens, Athens, Greece

    Stavros Liatis & Konstantinos Makrilakis

  10. Department of Family and Occupational Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary

    Anna Nanasi & Imre Rurik

  11. Department of Diabetology, Clinical Center of Endocrinology, Medical University Sofia, Sofia, Bulgaria

    Tsvetalina Tankova

Authors
  1. Jemina Kivelä
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katja Wikström
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eeva Virtanen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Georgoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Greet Cardon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fernando Civeira
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Violeta Iotova
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ernest Karuranga
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Winne Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Stavros Liatis
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Konstantinos Makrilakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yannis Manios
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Rocío Mateo-Gallego
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Anna Nanasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Imre Rurik
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Tsvetalina Tankova
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Kaloyan Tsochev
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Vicky Van Stappen
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Jaana Lindström
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the Feel4Diabetes research group

  • Yannis Manios
  • , Greet Cardon
  • , Jaana Lindström
  • , Peter Schwarz
  • , Konstantinos Makrilakis
  • , Lieven Annemans
  • , Ignacio Garamendi
  • , Meropi Kontogianni
  • , Odysseas Androutsos
  • , Christina Mavrogianni
  • , Konstantina Tsoutsoulopoulou
  • , Christina Katsarou
  • , Eva Karaglani
  • , Irini Qira
  • , Efstathios Skoufas
  • , Konstantina Maragkopoulou
  • , Antigone Tsiafitsa
  • , Irini Sotiropoulou
  • , Michalis Tsolakos
  • , Effie Argyri
  • , Mary Nikolaou
  • , Eleni-Anna Vampouli
  • , Christina Filippou
  • , Katerina Gatsiou
  • , Efstratios Dimitriadis
  • , Tiina Laatikainen
  • , Katja Wikström
  • , Jemina Kivelä
  • , Päivi Valve
  • , Esko Levälahti
  • , Eeva Virtanen
  • , Vicky Van Stappen
  • , Nele Huys
  • , Ruben Willems
  • , Samyah Shadid
  • , Ivonne Panchyrz
  • , Maxi Holland
  • , Patrick Timpel
  • , Stavros Liatis
  • , George Dafoulas
  • , Christina-Paulina Lambrinou
  • , Angeliki Giannopoulou
  • , Lydia Tsirigoti
  • , Evi Fappa
  • , Costas Anastasiou
  • , Konstantina Zachari
  • , Lala Rabemananjara
  • , Maria Stella de Sabata
  • , Winne Ko
  • , Luis Moreno
  • , Fernando Civeira
  • , Gloria Bueno
  • , Pilar De Miguel-Etayo
  • , Esther Mª. Gonzalez-Gil
  • , Maria I. Mesana
  • , Germán Vicente-Rodriguez
  • , Gerardo Rodriguez
  • , Lucia Baila-Rueda
  • , Ana Cenarro
  • , Estíbaliz Jarauta
  • , Rocío Mateo-Gallego
  • , Violeta Iotova
  • , Tsvetalina Tankova
  • , Natalia Usheva
  • , Kaloyan Tsochev
  • , Nevena Chakarova
  • , Sonya Galcheva
  • , Rumyana Dimova
  • , Yana Bocheva
  • , Zhaneta Radkova
  • , Vanya Marinova
  • , Yuliya Bazdarska
  • , Tanya Stefanova
  • , Imre Rurik
  • , Timea Ungvari
  • , Zoltán Jancsó
  • , Anna Nánási
  • , László Kolozsvári
  • , Csilla Semánova
  • , Remberto Martinez
  • , Marcos Tong
  • , Kaisla Joutsenniemi
  •  & Katrina Wendel-Mitoraj

Contributions

JK and JL constructed the search strategy for primary review and they also read and selected articles. MG conducted the complementary search. JK, KW, MG and JL wrote the first draft of the manuscript. EV, GC, FC, VI, EK, WK, SL, KM, YM, RMG, AN, IR, TT KT, VVS critically revised the manuscript and read and approved the final manuscript.

Corresponding author

Correspondence to Jemina Kivelä.

Ethics declarations

Ethics approval and consent to participate

The Feel4Diabetes study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects were approved by the ethics committees in all countries (in Belgium, by the Medical Ethics Committee of the Ghent University Hospital; in Bulgaria, by the Ethics Committee of the Medical University of Varna; in Finland, by the hospital district of Southwest Finland ethical committee; in Greece, by the Bioethics Committee of Harokopio University; in Hungary, by the National Committee for Scientific Research in Medicine; in Spain, by the Clinical Research Ethics Committee). Written informed consent was obtained from all subjects.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kivelä, J., Wikström, K., Virtanen, E. et al. Obtaining evidence base for the development of Feel4Diabetes intervention to prevent type 2 diabetes – a narrative literature review. BMC Endocr Disord 20 (Suppl 1), 140 (2020). https://doi.org/10.1186/s12902-019-0468-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12902-019-0468-y

Keywords

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us